These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 232302

  • 1. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
    Homenko AG, Ciukanov VL.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
    [Abstract] [Full Text] [Related]

  • 2. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG, Karachunskiĭ MA, Dorozhkova IR, Chukanov VI, Balta IuE.
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract] [Full Text] [Related]

  • 3. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG.
    Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
    [Abstract] [Full Text] [Related]

  • 4. [A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].
    González Montaner LF, Garay C, Abbate EH, Albareda MA.
    Prax Klin Pneumol; 1978 Jul; 32(7):488-90. PubMed ID: 98759
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term treatment of tuberculosis with isoprodian (author's transl)].
    Bergsmann O, Spielmann E.
    Wien Klin Wochenschr; 1979 Aug 10; 91(15):513-6. PubMed ID: 473771
    [Abstract] [Full Text] [Related]

  • 6. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 11; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
    Opl G, Benkö M.
    Prax Pneumol; 1977 Feb 11; 31(2):116-20. PubMed ID: 846937
    [No Abstract] [Full Text] [Related]

  • 11. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 11; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 12. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J.
    Pneumonol Pol; 1976 Sep 11; 44(1):55-60. PubMed ID: 821043
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 11; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 11; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
    Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R.
    Tuber Lung Dis; 1993 Feb 11; 74(1):23-7. PubMed ID: 8495016
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.